(1)
A Predictive In Vitro Biorelevant Dissolution Method Development for Fluvoxamine Extended-Release Capsules by Simulating Preprandial and Postprandial In Vivo Performance. AJP 2020, 14 (4). https://doi.org/10.22377/ajp.v14i4.3820.